Article

ForbesForbes on 2019-10-07 11:20

How Does Bristol-Myers Squibb’s Valuation Compare To Its Peers?

Bristol-Myers Squibb’s market cap is much lower than some of the large pharmaceuticals companies, including J&J, Merck, and Pfizer. Despite ...

Related news